| Literature DB >> 30784001 |
Ken-Ichi Nakashima1, Junko Tomida2, Takao Hirai3, Yoshiaki Kawamura2, Makoto Inoue3.
Abstract
Three new sesquiterpenes, phlebidiol, phlebioic acid, and phlebiolide, as well as the known compound tremetriol, were isolated from cultures of the basidiomycete Phlebia tremellosa. The structures of all isolated compounds were established by extensive spectroscopic analyses, including those involving extensive two-dimensional nuclear magnetic resonance. The absolute configurations of phlebidiol, phlebioic acid, and phlebiolide were determined by comparisons of experimental and calculated electronic circular dichroism spectra. Phlebidiol and phlebioic acid have previously unreported carbon skeletons, for which we propose the skeletal names "seco-sterpurane" and "phlebiane," respectively. Phlebiolide is also the second published example of a merulane sesquiterpene.Entities:
Keywords: Basidiomycetes; Phlebia tremellosa; Phlebiane; Seco-sterpurane; Sesquiterpenoids
Mesh:
Substances:
Year: 2019 PMID: 30784001 PMCID: PMC7188727 DOI: 10.1007/s11418-019-01286-8
Source DB: PubMed Journal: J Nat Med ISSN: 1340-3443 Impact factor: 2.343
Fig. 1Chemical structures of compounds isolated from Phlebia tremellosa
1H and 13C NMR data (400 and 100 MHz) of compounds 1–3 in deuterochloroform (CDCl3)
| No. | Phlebidiol ( | Phlebioic acid ( | Phlebiolide ( | |||
|---|---|---|---|---|---|---|
| 1 | 159.9 | 132.8 | 132.0 | |||
| 2α | 2.25 (1H, d, | 43.4 | 208.2 | 5.84 (1H, d, | 144.9 | |
| 2β | 2.46 (1H, d, | |||||
| 3 | 39.5 | 49.4 | 46.3 | |||
| 4α | 3.35 (1H, d, | 84.4 | 3.43 (1H, d, | 81.2 | 2.33 (1H, dd, | 45.1 |
| 4β | 1.75 (1H, dd, | |||||
| 5 | 2.86 (1H, m)a | 42.8 | 2.70 (1H, m)b | 41.2 | 3.21 (1H, m) | 47.9 |
| 6α | 1.55 (1H, dd, | 40.7 | 2.08 (2H, m) | 38.9 | 2.66 (1H, d, | 66.0 |
| 6β | 2.19 (1H, dd, | |||||
| 7 | 42.6 | 44.2 | 61.0 | |||
| 8α | 204.1 | 2.10 (1H, m) | 34.0 | 2.95 (1H, d, | 30.5 | |
| 8β | 1.77 (1H, br t, | 2.57 (1H, br d, | ||||
| 9α | 128.4 | 2.54 (1H, dd, | 34.7 | 122.9 | ||
| 9β | 2.28 (1H, dd, | |||||
| 10 | 1.02 (3H, s) | 21.9 | 155.8 | 174.3 | ||
| 11 | 1.14 (3H, s) | 27.4 | 1.00 (3H, s) | 17.8 | 4.82 (1H, dd, | 69.2 |
| 4.87 (1H, dd, | ||||||
| 12 | 1.85 (1H, dt, | 37.8 | 1.11 (3H, s) | 21.7 | 153.8 | |
| 1.64 (1H, m) | ||||||
| 13 | 3.73 (2H, m) | 59.2 | 1.35 (3H, s) | 24.8 | 1.23 (3H, s) | 29.6 |
| 14 | 1.16 (3H, s) | 23.6 | 182.8 | 1.11 (3H, s) | 28.1 | |
| 15 | 1.64 (3H, br s)a | 11.2 | 2.19 (3H, d, | 22.3 | 1.33 (3H, s) | 23.0 |
a–dSignals are coupled homoallylically with each other
Fig. 2Key HMBC (arrows) and double-quantum filtered (DQF)–COSY (bold) correlations in 1–3
Fig. 3a Key NOESY correlations (arrows) in phlebidiol (1). b Comparing the experimental electronic circular dichroism (ECD) spectrum of 1 with the calculated ECD spectrum of (4R, 5S, 7R)-1
Fig. 4a Key NOESY correlations (arrows) in phlebioic acid (2). b Comparison of the experimental ECD spectrum of 2 with the calculated ECD spectrum of (4R, 5S, 7S)-2
Fig. 5a Key NOESY correlations (arrows) in phlebiolide (3). b Comparison of the experimental ECD spectrum of 3 with the calculated ECD spectrum of (5R, 6S, 7R)-3
Fig. 6Plausible biogenetic pathways of 1–3